NASDAQ:SGEN Seagen (SGEN) Stock Forecast, Price & News $193.49 -0.95 (-0.49%) (As of 05/26/2023 ET) Add Compare Share Share Today's Range$192.50▼$195.7450-Day Range$187.64▼$206.2552-Week Range$116.08▼$207.16Volume1.26 million shsAverage Volume1.70 million shsMarket Capitalization$36.28 billionP/E RatioN/ADividend YieldN/APrice Target$190.47 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Seagen MarketRank™ ForecastAnalyst RatingHold2.35 Rating ScoreUpside/Downside1.6% Downside$190.47 Price TargetShort InterestHealthy3.41% of Shares Sold ShortDividend StrengthN/ASustainability-2.11Upright™ Environmental ScoreNews Sentiment0.92Based on 7 Articles This WeekInsider TradingSelling Shares$30.56 M Sold Last QuarterProj. Earnings GrowthGrowingFrom ($2.96) to ($0.98) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.00 out of 5 starsMedical Sector653rd out of 1,012 stocksBiological Products, Except Diagnostic Industry100th out of 169 stocks 2.2 Analyst's Opinion Consensus RatingSeagen has received a consensus rating of Hold. The company's average rating score is 2.35, and is based on 6 buy ratings, 11 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $190.47, Seagen has a forecasted downside of 1.6% from its current price of $193.49.Amount of Analyst CoverageSeagen has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock. Previous Next 3.0 Short Interest Percentage of Shares Shorted3.41% of the outstanding shares of Seagen have been sold short.Short Interest Ratio / Days to CoverSeagen has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Seagen has recently increased by 15.76%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldSeagen does not currently pay a dividend.Dividend GrowthSeagen does not have a long track record of dividend growth. Previous Next 2.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreSeagen has received a 24.38% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Brentuximab vedotin", "Enfortumab vedotin", and "Tucatinib" products. See details.Environmental SustainabilityThe Environmental Impact score for Seagen is -2.11. Previous Next 2.2 News and Social Media Coverage News SentimentSeagen has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.73 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 7 news articles for Seagen this week, compared to 8 articles on an average week.Search InterestOnly 1 people have searched for SGEN on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat FollowsOnly 5 people have added Seagen to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 4.2 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Seagen insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $30,559,184.00 in company stock.Percentage Held by Insiders25.90% of the stock of Seagen is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions86.25% of the stock of Seagen is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Seagen are expected to grow in the coming year, from ($2.96) to ($0.98) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Seagen is -55.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Seagen is -55.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSeagen has a P/B Ratio of 13.33. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Seagen (NASDAQ:SGEN) StockSeagen Inc. is a biotechnology company, which engages in the development and commercialization of targeted therapies for the treatment of cancer. It also engages in the advancement of therapies for solid tumors and blood-related cancers. Its products include Adcetris, Padcev, Tivdak, and Tukysa. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA.Read More Receive SGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter. Email Address SGEN Stock News HeadlinesMay 19, 2023 | marketbeat.comIs Pfizer's Seagen Deal In Jeopardy Amid Antitrust Scrutiny? (SGEN)Despite worries about FTC scrutiny, Pfizer remains optimistic about its planned Seagen acquisition, issuing $31 billion in bonds to finance the deal.May 28, 2023 | americanbankingnews.comStockNews.com Begins Coverage on Seagen (NASDAQ:SGEN)May 28, 2023 | Stocks To Trade (Ad)15 A.I. Trading Opportunities a DayUsing our algorithm, we sift through 15,000 stocks every second. We generate 15 trading opportunities a day.May 23, 2023 | msn.com$100 Invested In This Stock 20 Years Ago Would Be Worth $4,000 TodayMay 21, 2023 | americanbankingnews.comSeagen Inc. (NASDAQ:SGEN) EVP Sells $66,261.14 in StockMay 21, 2023 | americanbankingnews.comSeagen (NASDAQ:SGEN) Research Coverage Started at StockNews.comMay 21, 2023 | americanbankingnews.comAnalysts Set Seagen Inc. (NASDAQ:SGEN) PT at $194.73May 18, 2023 | seekingalpha.comSeagen, Prometheus Biosciences fall amid news of FTC planned block of Horizon/Amgen dealMay 28, 2023 | Legacy Research (Affiliate) (Ad)Sell every Stock except ONE Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...May 18, 2023 | reuters.comPfizer to raise $31 billion for Seagen takeover in largest debt offeringMay 18, 2023 | finance.yahoo.comSeagen (SGEN) Rose on Acquisition AnnouncementMay 18, 2023 | americanbankingnews.comSeagen (NASDAQ:SGEN) Shares Gap Down on Insider SellingMay 18, 2023 | americanbankingnews.comSeagen (NASDAQ:SGEN) Shares Gap Down Following Insider SellingMay 18, 2023 | americanbankingnews.comInsider Selling: Seagen Inc. (NASDAQ:SGEN) Director Sells 1,864 Shares of StockMay 18, 2023 | americanbankingnews.comInvestors Buy Large Volume of Put Options on Seagen (NASDAQ:SGEN)May 17, 2023 | reuters.comPfizer plans to raise $31 bln from debt offering to finance Seagen takeoverMay 17, 2023 | marketwatch.comNasdaq 100 Movers: SGEN, AMDMay 17, 2023 | reuters.comPfizer to raise $31 bln for Seagen takeover in largest debt offeringMay 17, 2023 | finance.yahoo.comPfizer (PFE) to Raise $31B in Debt to Fund Seagen (SGEN) DealMay 16, 2023 | wsj.comSeagen Inc.May 16, 2023 | msn.comUnusual Put Option Trade in Seagen (SGEN) Worth $5,030.00KMay 16, 2023 | markets.businessinsider.comSeagen (SGEN) Receives a Hold from Berenberg BankMay 16, 2023 | msn.comSeagen (SGEN) Stock Falls 6% After Director Sells SharesMay 16, 2023 | finance.yahoo.comSeagen (NASDAQ:SGEN) shareholders have earned a 29% CAGR over the last five yearsMay 15, 2023 | msn.com(SGEN) - Analyzing Seagen's Short InterestMay 15, 2023 | americanbankingnews.comSeagen Inc. (NASDAQ:SGEN) Sees Large Increase in Short InterestMay 13, 2023 | americanbankingnews.comSeagen (NASDAQ:SGEN) Earns Hold Rating from Analysts at StockNews.comSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive SGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Seagen and its competitors with MarketBeat's FREE daily newsletter. Email Address SGEN Company Calendar Last Earnings4/27/2023Today5/28/2023Next Earnings (Estimated)7/27/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Biological products, except diagnostic Sub-IndustryBiotechnology SectorMedical Current SymbolNASDAQ:SGEN CUSIP81257810 CIK1060736 Webwww.seattlegenetics.com Phone(425) 527-4000Fax425-527-4001Employees3,256Year Founded1998Price Target and Rating Average Stock Price Forecast$190.47 High Stock Price Forecast$229.00 Low Stock Price Forecast$129.00 Forecasted Upside/Downside-1.6%Consensus RatingHold Rating Score (0-4)2.35 Research Coverage17 Analysts Profitability EPS (Most Recent Fiscal Year)($3.49) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-610,310,000.00 Net Margins-31.55% Pretax Margin-31.00% Return on Equity-23.00% Return on Assets-17.93% Debt Debt-to-Equity RatioN/A Current Ratio3.65 Quick Ratio2.98 Sales & Book Value Annual Sales$2.06 billion Price / Sales17.65 Cash FlowN/A Price / Cash FlowN/A Book Value$14.52 per share Price / Book13.33Miscellaneous Outstanding Shares187,504,000Free Float138,940,000Market Cap$36.28 billion OptionableOptionable Beta0.54 Social Links Key ExecutivesDavid R. EpsteinChief Executive Officer & DirectorTodd E. SimpsonChief Financial OfficerVaughn B. HimesChief Technical OfficerRoger D. DanseyChief Medical Officer & President-ResearchKarin A. TollefsonSenior VP & Head-Global Medical AffairsKey CompetitorsBiogenNASDAQ:BIIBRepligenNASDAQ:RGENGilead SciencesNASDAQ:GILDAmgenNASDAQ:AMGNBioNTechNASDAQ:BNTXView All CompetitorsInsiders & InstitutionsProShare Advisors LLCBought 9,166 shares on 5/26/2023Ownership: 0.091%Water Island Capital LLCBought 108,429 shares on 5/25/2023Ownership: 0.058%Verity Asset Management Inc.Sold 147 shares on 5/24/2023Ownership: 0.003%Mint Tower Capital Management B.V.Bought 2,200 shares on 5/24/2023Ownership: 0.001%Seaport Global Advisors LLCBought 1,409 shares on 5/23/2023Ownership: 0.002%View All Insider TransactionsView All Institutional Transactions SGEN Stock - Frequently Asked Questions Should I buy or sell Seagen stock right now? 17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Seagen in the last year. There are currently 11 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" SGEN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SGEN, but not buy additional shares or sell existing shares. View SGEN analyst ratings or view top-rated stocks. What is Seagen's stock price forecast for 2023? 17 Wall Street research analysts have issued 1 year target prices for Seagen's shares. Their SGEN share price forecasts range from $129.00 to $229.00. On average, they expect the company's stock price to reach $190.47 in the next twelve months. This suggests that the stock has a possible downside of 1.6%. View analysts price targets for SGEN or view top-rated stocks among Wall Street analysts. How have SGEN shares performed in 2023? Seagen's stock was trading at $128.51 at the start of the year. Since then, SGEN shares have increased by 50.6% and is now trading at $193.49. View the best growth stocks for 2023 here. When is Seagen's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Thursday, July 27th 2023. View our SGEN earnings forecast. How were Seagen's earnings last quarter? Seagen Inc. (NASDAQ:SGEN) posted its earnings results on Thursday, April, 27th. The biotechnology company reported ($0.93) earnings per share for the quarter, missing the consensus estimate of ($0.82) by $0.11. The biotechnology company earned $519.70 million during the quarter, compared to analyst estimates of $516.28 million. Seagen had a negative net margin of 31.55% and a negative trailing twelve-month return on equity of 23.00%. The firm's quarterly revenue was up 21.9% compared to the same quarter last year. During the same period last year, the company posted ($0.74) earnings per share. What ETFs hold Seagen's stock? ETFs with the largest weight of Seagen (NASDAQ:SGEN) stock in their portfolio include First Trust NYSE Arca Biotechnology Index Fund (FBT), IQ Merger Arbitrage ETF (MNA), Principal Healthcare Innovators ETF (BTEC), VanEck Biotech ETF (BBH), Vesper U.S. Large Cap Short-Term Reversal Strategy ETF (UTRN), iShares Biotechnology ETF (IBB), Invesco Nasdaq Biotechnology ETF (IBBQ) and Goldman Sachs Future Health Care Equity ETF (GDOC). What is Clay B. Siegall's approval rating as Seagen's CEO? 107 employees have rated Seagen Chief Executive Officer Clay B. Siegall on Glassdoor.com. Clay B. Siegall has an approval rating of 99% among the company's employees. This puts Clay B. Siegall in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Seagen own? Based on aggregate information from My MarketBeat watchlists, some companies that other Seagen investors own include NVIDIA (NVDA), AbbVie (ABBV), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Salesforce (CRM), QUALCOMM (QCOM), Tesla (TSLA), Micron Technology (MU), Netflix (NFLX) and Alibaba Group (BABA). What is Seagen's stock symbol? Seagen trades on the NASDAQ under the ticker symbol "SGEN." Who are Seagen's major shareholders? Seagen's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Baker BROS. Advisors LP (25.02%), BlackRock Inc. (5.97%), Wellington Management Group LLP (3.64%), State Street Corp (1.79%), Geode Capital Management LLC (1.05%) and Avoro Capital Advisors LLC (0.96%). Insiders that own company stock include Bros Advisors Lp Baker, Charles R Romp, Charles R Romp, Clay B Siegall, Clay B Siegall, Daniel G Welch, Daniel G Welch, David W Gryska, David W Gryska, Jean I Liu, Jean I Liu, Morgan E Obrien, Roger D Dansey, Roger D Dansey, Todd E Simpson, Todd E Simpson, Vaughn B Himes and Vaughn B Himes. View institutional ownership trends. How do I buy shares of Seagen? Shares of SGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Seagen's stock price today? One share of SGEN stock can currently be purchased for approximately $193.49. How much money does Seagen make? Seagen (NASDAQ:SGEN) has a market capitalization of $36.28 billion and generates $2.06 billion in revenue each year. The biotechnology company earns $-610,310,000.00 in net income (profit) each year or ($3.49) on an earnings per share basis. How many employees does Seagen have? The company employs 3,256 workers across the globe. Does Seagen have any subsidiaries? The following companies are subsidiares of Seagen: Cascadian Therapeutics.Read More How can I contact Seagen? Seagen's mailing address is 21823 30TH DRIVE SE SUITE, BOTHELL WA, 98021. The official website for the company is www.seattlegenetics.com. The biotechnology company can be reached via phone at (425) 527-4000, via email at investors@seagen.com, or via fax at 425-527-4001. This page (NASDAQ:SGEN) was last updated on 5/28/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Seagen Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.